Alanine aminotransferase and γ-glutamyltransferase as markers for elevated insulin resistance-associated metabolic abnormalities in obese Japanese men younger than 30 years of age

Obesity Research and Clinical Practice

Volumn 4, Issue 1, 2010, Pages

  Koike, Teruhiko ^a,b   Miyamoto, Maiko ^b   Oshida, Yoshiharu ^a,b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

Insulin resistance; Liver function test; Obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE MARKER; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; JAPANESE; LIPOPROTEIN BLOOD LEVEL; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OBESITY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 74449086260     PISSN: 1871403X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.orcp.2009.09.003     Document Type: Article

References (20)

1. Yazaki Y., and Kadowaki T. Combating diabetes and obesity in Japan. Nat Med 12 1 (2006) 73-74
2. Kadowaki T., Miyake Y., Hagura R., Akanuma Y., Kajinuma H., Kuzuya N., et al. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia 26 1 (1984) 44-49
3. Koike T., Miyamoto M., and Oshida Y. Waist circumference is positively associated with insulin resistance but not with fasting blood glucose among moderately to highly obese young Japanese men. Obes Res Clin Prac 3 (2009) 109-114
4. Zivkovic A.M., German J.B., and Sanyal A.J. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr 86 (2007) 285-300
5. McCullough A.J. Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol 40 3 Suppl. 1 (2006) S17-29
6. Gaemers I.C., and Groen A.K. New insights in the pathogenesis of non-alcoholic fatty liver disease. Curr Opin Lipidol 17 3 (2006) 268-273
7. Clark J.M. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 40 Suppl. 1 (2006) S5-S10
8. den Boer M., Voshol P.J., Kuipers F., Havekes L.M., and Romijn J.A. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models. Arterioscler Thromb Vasc Biol 24 4 (2004) 644-649
9. Hanley A.J., Wagenknecht L.E., Festa A., D'Agostino Jr. R.B., and Haffner S.M. Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study. Diabetes Care 30 7 (2007) 1819-1827
10. Andre P., Balkau B., Vol S., Charles M.A., Eschwege E., and DESIR Study Group. γ-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort. Diabetes Care 30 9 (2007) 2355-2361
11. Nakanishi N., Suzuki K., and Tatara K. Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 27 6 (2004) 1427-1432
12. Hanley A.J., Williams K., Festa A., Wagenknecht L.E., D'Agostino Jr. R.B., and Haffner S.M. Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes 54 11 (2005) 3140-3147
13. André P., Balkau B., Born C., Royer B., Wilpart E., Charles M.A., et al. Hepatic markers and development of type 2 diabetes in middle aged men and women: a three-year follow-up study. The D.E.S.I.R. Study (data from an Epidemiological Study on the Insulin Resistance syndrome). Diabetes Metab 31 6 (2005) 542-550
14. Westerbacka J., Cornér A., Tiikkainen M., Tamminen M., Vehkavaara S., Häkkinen A.M., et al. Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia 47 (2004) 1360-1369
15. Vozarova B., Stefan N., Lindsay R.S., Saremi A., Pratley R.E., Bogardus C., et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51 (2002) 1889-1895
16. Whitfield J.B. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 38 4 (2001) 263-355
17. Marchesini G., Brizi M., Bianchi G., Tomassetti S., Bugianesi E., Lenzi M., et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50 8 (2001) 1844-1850
18. Lee D.H., Blomhoff R., and Jacobs Jr. D.R. Is serum gamma glutamyltransferase a marker of oxidative stress?. Free Radic Res 38 6 (2004) 535-539
19. Lee D.H., Ha M.H., Kam S., Chun B., Lee J., Song K., et al. A strong secular trend in serum gamma-glutamyltransferase from 1996 to 2003 among South Korean men. Am J Epidemiol 163 1 (2006) 57-65
20. McAuley K.A., Mann J.I., Chase J.G., Lotz T.F., and Shaw G.M. Point: HOMA-satisfactory for the time being: HOMA: the best bet for the simple determination of insulin sensitivity, until something better comes along. Diabetes Care 30 9 (2007) 2411-2413